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Sickle cell disease (SCD) is associated with clinically signiﬁcant
cerebrovascular complications inupto30%ofpatients including
increased risk of thromboembolism [1]. It may also result in
intracranial aneurysm formation which are generally multiple
and is thought to be due to recurrent red cell sickling [2]. Sickle
cell trait (SCT), a carrier conditionmay also rarelymanifest with
features of SCD. Craniotomy and clipping may pose operative
risk of surgery in SCD and SCT [3]. The literature is sparse
regardingsafetyandefﬁcacyofendovascularprocedures insuch
patients. The electric detachment of coils in SCD may enhance
the risk of thrombosis due to intraluminal current that may be
compounded with intimal burn. We report a case of aneurysm
managed in SCT by endovascular coiling and technical aspects
of it using mechanical detachment system (MDS) with good
radiological and functional outcome. This study was exempt
from getting an ethical permission in our institution and the
patient as well as the relatives agreed that this case will be an
object of scientiﬁc observation and publication.
A 47-year old female, known case of SCT, presented to us
withthechiefcomplaintsofsuddenonsetholocranialheadache
with recurrent episodes of vomiting for past 3 days. There was
no history of any other co-morbidities. Neurological examina-
tion revealed no sensory and motor deﬁcit with normal cranial
nerve examination ﬁndings. Non-contrast computed tomogra-
phy (NCCT) of brain revealed sub arachnoidhaemorrhage in the
basal cisterns. CT angiography of the brain was suggestive of
single saccular multilobed left internal carotid artery supracli-
noid aneurysmmeasuring 11X13X23 mmwhichwas conﬁrmed
by a preoperative digital subtraction angiogram (DSA) (Fig. 1a).Contrastenhancedcomputed tomography (CECT) chestwithCT
angiography and CECT abdomen was obtained to rule out
thrombosis which was negative. Ophthalmological evaluation
and routine blood and urine investigationswere within normal
limits. Routine methods to detect haemolysis including biliru-
bin and lactate dehydrogenase (LDH) were negative. After
informed consent, patient was taken up for endovascular
coiling via transfemoral route using MDS. The postoperative
DSA revealeda satisfactory angiographic occlusion (Fig. 1b). She
had uneventful recovery in the postoperative period with
neither a sickle crisis occurring nor exchange transfusion
needed and was discharged in a satisfactory condition.
Neurological complications occur in 18–29% of patients with
homozygous HbS sickle cell disease [4]. The literature has
documented only few cases of SAH secondary to cerebrovascu-
laraneurysms inpatientswithSCDandfurthervery fewcases in
patients with SCT. Cerebral infarction results in over 75% of the
neurological complications while intracerebral haemorrhage
and SAH develops in 20% and 1–2% respectively [5].
Intracranial aneurysms are an infrequent complication of
SCD and they are not associated with usual risk factors of
aneurysm formation like hypertension, arteriosclerosis, ciga-
rette smoking or connective tissue disease [2] but are proposed
to be acquired from vascular damage secondary to hypoxia, red
cell sickling, endothelial injury, vessel wall degeneration and
vascular occlusion [1,2]. Stehbens attributed saccular aneur-
ysms tohemodynamically induceddegenerative changes in the
arterial wall related to atherosclerosis resulting in the loss of
tensile strength; these acquired changes are pre-aneurysmal in
nature [6].
The management of SAH and cerebral aneurysm in
patients with SCD is associated with the development of
sickle cell crisis due to hypoxia, acidosis and hypothermia, and
also with the use of radiological contrast media in these
patients. Traditionally these aremanaged by open aneurysmal
clipping because a concern in these patients is that coiling
increases the risk of local sickling and arterial occlusion [3].
However, the endovascular technique has the advantages that
access to inoperable aneurysms may be attainable, cranioto-
my is avoided, and the procedure sometimes can be performed
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Fig. 1 – (a) Lateral view DSA of left ICA depicting single saccular multilobed aneurysm arising from supraclinoid segment of
left Internal carotid artery measuring 11X13X23 mm. (b) Postoperative angiogram revealing the coiled obliterated aneurysm
with mild spasm in ICA.
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is associated with increased rates of morbidity (18%) and
mortality (24%), this procedure has demonstrated morbidity
and mortality rates of only 8.5% and 4% respectively [7]. With
either treatment strategy, intraoperative management in SCD
patients should include adequate oxygenation to prevent
tissue hypoxia and to avoid hypothermia and venous stasis to
reduce the occurrence of intravascular sickling. Packed red
blood cell transfusion preoperatively to accomplish a goal HbS
of 30% and the use of newer non-ionic contrast media have
reduced the complication rate during diagnostic and thera-
peutic endovascular procedures.
Although coiling is usually safe and effective, various
complications namely procedure-related rupture of the aneu-
rysm, thromboembolic phenomenon related to the delivery
system or coil, occlusion of the parent artery by protruded coils
may occur [7]. However, the most common are ischaemic
complicationsresulting fromthrombosisof thearteryanddistal
embolic phenomena from embolized aneurysms or related
devices. Pelzetal. in their seriesof cerebral aneurysms, reported
the incidenceof strokeswithendovascular treatmentbeing 28%
[8] while Rordorf and colleagues noticed a 61% incidence of
silent thromboembolic episodes with such procedures [9].
Potential sources of thromboembolic events can be catheters,
partially occluded aneurysmal sac or pre-existing thrombi
within the aneurysmal sac and coil mass surface.
Literature is sparse regarding best modality of treatment of
intracranial aneurysms in SCD patients. Medline search
returned zero results regarding utility of MDS in SCT patients.
Since SCT patients are already predisposed to thrombosis,
MDS was a preferred modality over EDS in the current case as
the latter is associated with higher incidence of thromboem-
bolic complications which is further compounded by intimal
burn. Embolization with MDS, on the other hand is rapid with
little or no chances of thromboembolic complications and theprocess does not deliver heat at the aneurysmal site [10]. With
the experience of the current case, we conclude that MDSmay
be a favoured option in SCT patients.
Although there are no randomized trials comparing
treatments of cerebral aneurysms in patients with SCD/SCT,
with improved medical management of pre- and postopera-
tive haematological status and careful anaesthetic techniques,
we strongly recommend these patients be considered for
endovascular coiling using MDS. However, active and com-
plete management of the underlying sickling disorder is
mandatory. A further concern is the role of this procedure in
long term aneurysmal ablation.
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